Trial Profile
Phase III trial of sotatercept for the treatment of anaemia in patients with myelodysplastic syndromes
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2015
Price :
$35
*
At a glance
- Drugs Sotatercept (Primary)
- Indications Anaemia
- Focus Adverse reactions; Therapeutic Use
- 17 Mar 2015 New trial record